Back
iShares Core MSCI Emerging Markets ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
65
IEMG
iShares Core MSCI Emerging Markets ETF
Last Price:
$69.76
Seasonality Move:
0.24%
Buy
67
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$90.03
Seasonality Move:
-24.59%
Buy
65
iShares Core MSCI Emerging Markets ETF (IEMG)
is a Buy
Is iShares Core MSCI Emerging Markets ETF a Buy, Sell or Hold?
-
The current iShares Core MSCI Emerging Markets ETF [IEMG] share price is $69.78. The Score for IEMG is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
IEMG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $90.01. The Score for DRUG is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IEMG Stock Price Chart
What is iShares Core MSCI Emerging Markets ETF's stock price today?
-
The iShares Core MSCI Emerging Markets ETF share price today is $69.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IEMG is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $90.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.
IEMG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 67.05 | Buy |
| Chaikin Money Flow: | 18521266 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (65.98 - 68.66) | Buy |
| Bollinger Bands (100): | (63.95 - 68.21) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.79 | Buy |
| Relative Strength Index (14 RSI): | 58.71 | Buy |
| Chaikin Money Flow: | -196363 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (75.34 - 89.1) | Buy |
| Bollinger Bands (100): | (46.01 - 75.51) | Buy |
IEMG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.59 | Buy |
| 20-day SMA: | 67.36 | Buy |
| 50-day SMA: | 67.46 | Buy |
| 200-day SMA: | 61.65 | Buy |
| 8-day EMA: | 68.79 | Buy |
| 20-day EMA: | 67.83 | Buy |
| 50-day EMA: | 66.43 | Buy |
| 200-day EMA: | 44.37 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.17 | Buy |
| 20-day SMA: | 84.39 | Buy |
| 50-day SMA: | 70.26 | Buy |
| 200-day SMA: | 45.73 | Buy |
| 8-day EMA: | 86.85 | Buy |
| 20-day EMA: | 82.54 | Buy |
| 50-day EMA: | 73.48 | Buy |
| 200-day EMA: | 51.43 | Buy |
iShares Core MSCI Emerging Markets ETF Earnings Growth & IEMG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.03 per share, and a decrease next year of $3.86 per share.
iShares Core MSCI Emerging Markets ETF Technical Analysis
| Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||